News: SRX Australia's Sirtex Medical accepts $1.4 bln offer from China's CDH Investments

June 14 (Reuters) - Liver cancer treatment firm Sirtex Medical Ltd (SRX) said on Thursday its board has recommended an offer from China's CDH Investments to buy the firm for A$1.87 billion ($1.41 billion).

The deal will result in the termination of an agreement to sell itself to Varian Medical Systems Inc VAR.N , it said in a statement.

CDH and its partner, China Grand Pharmaceutical and Healthcare Holdings Ltd 0512.HK , had offered to pay A$33.60 per share in cash in May. ($1 = 1.3226 Australian dollars)